Summary

Infectious diseases are illnesses caused by the introduction of harmful microorganisms (pathogens or germs) into the body. They can affect humans, animals, and even plants. Historically, infectious diseases have been a major cause of death worldwide, though advancements in public health measures like vaccines and antibiotics have significantly reduced their impact in many areas. Despite these advances, infectious diseases remain a significant global health challenge, especially in low-income countries.

OnAir Post: Infectious Diseases

About

Source: Gemini AI Overview

Causes of infectious diseases

  • Bacteria
    One-celled organisms responsible for illnesses such as strep throat, urinary tract infections, and tuberculosis.

  • Viruses
    Even smaller than bacteria, viruses cause diseases like the common cold, COVID-19, HIV, and influenza.

  • Fungi
    Responsible for skin conditions like ringworm and athlete’s foot, and can also infect internal organs.

  • Parasites
    Organisms like those causing malaria (spread by mosquitoes) or infections from animal feces.

  • Prions
    Rarely, these infectious proteins can cause diseases like Creutzfeldt-Jakob disease.     

Transmission of infectious diseases

  • Direct contact
    This involves touching, kissing, coughing or sneezing on another person, or engaging in sexual contact.

  • Animal to person
    Bites or scratches from infected animals, as well as contact with animal waste, can transmit diseases.

  • Mother to child
    Infected mothers can transmit diseases to their unborn or newborn babies during pregnancy or childbirth.

  • Contaminated food or water
    Consumption of contaminated food or drinks can lead to illnesses like food poisoning or diarrhea-related diseases.

  • Environmental exposure
    Germs can survive on surfaces or in the environment and be picked up by individuals.

  • Vectors
    Insects like mosquitoes and ticks can act as carriers, transmitting diseases from one host to another. 

Symptoms and diagnosis

Symptoms of infectious diseases vary depending on the specific illness, but common symptoms include:
  • Fever
  • Fatigue
  • Muscle aches
  • Coughing
  • Diarrhea
  • Night sweats 
Diagnosis typically involves reviewing symptoms, conducting laboratory tests on body fluids (like blood, urine, or throat swabs), and sometimes using imaging scans like X-rays or biopsies for tissue samples.

Treatment

  • Antibiotics
    Effective against bacterial infections, but overuse can lead to antibiotic resistance.

  • Antivirals
    Medications for specific viral infections like COVID-19 or HIV.

  • Antifungals
    Used to treat fungal infections, sometimes in topical or oral forms.

  • Antiparasitics
    Drugs to combat parasitic infections like malaria.

Prevention

  • Vaccinations
    Immunization against preventable diseases like measles, mumps, rubella, and COVID-19.

  • Good hygiene
    Frequent handwashing, proper food handling, and cleaning surfaces.

  • Avoiding close contact with sick people
    Staying home when unwell to prevent further transmission.

  • Insect repellents and protective clothing
    To prevent diseases spread by vectors like mosquitoes and ticks.

  • Safe sex practices
    Using condoms to prevent sexually transmitted infections.     

Challenges

Infectious diseases pose a constant threat to global health, presenting a complex and evolving set of challenges. These challenges are influenced by a variety of factors, from environmental shifts to social and economic disparities.

Initial Source for content: Gemini AI Overview 7/16/25

[Enter your questions, feedback & content (e.g. blog posts, Google Slide or Word docs, YouTube videos) on the key issues and challenges related to this post in the “Comment” section below.  Post curators will review your comments & content and decide where and how to include it in this section.]

1. Antimicrobial Resistance (AMR)

One of the most pressing concerns is antimicrobial resistance, says the World Health Organization (WHO). This occurs when microbes like bacteria, viruses, fungi, and parasites evolve to withstand the effects of medicines designed to treat them.

The result is that infections become harder to treat, leading to prolonged illnesses, increased healthcare costs, and potentially deadly consequences. AMR is exacerbated by the misuse and overuse of antibiotics in both humans and animals. 

2. Emergence and re-emergence of diseases

  • Microbial adaptation and change
    Microbes are constantly evolving, developing new ways to evade our immune systems or become resistant to treatments.

  • Ecological changes
    Deforestation, urbanization, and climate change bring humans into closer contact with animal populations, facilitating the spread of zoonotic diseases (infections transmitted from animals to humans).

  • Human demographics and behavior
    Increased population density, travel, and certain behaviors (e.g., drug use, outdoor recreational activities) can accelerate the spread of pathogens.     

3. Climate change and infectious diseases

Climate change significantly impacts the emergence and spread of infectious diseases. Rising temperatures, extreme weather events like floods and droughts, and altered ecosystems can create favorable conditions for disease vectors (like mosquitoes and ticks) and increase the incidence of food- and waterborne illnesses.

4. Challenges in prevention and control

  • Vaccination gaps
    Declining vaccination rates or insufficient vaccine coverage allow diseases like measles and polio to resurface.

  • Weak surveillance systems
    Inadequate infrastructure for detecting and monitoring emerging infections, especially in resource-limited settings, can delay response efforts and allow outbreaks to escalate.

  • Access to healthcare
    Limited access to healthcare services, diagnostics, and essential medicines further complicates disease prevention and control.

5. Socioeconomic and political factors

Poverty, inequality, political instability, and misinformation can all hinder public health efforts to address infectious diseases, making it challenging to implement effective prevention strategies and ensure equitable access to care.

Addressing these complex challenges necessitates a concerted global effort, investment in healthcare infrastructure, sustained research and development of new treatments and vaccines, and a “One Health” approach that recognizes the interconnectedness of human, animal, and environmental health, according to the World Health Organization (WHO). 

Innovations

Infectious diseases pose a constant and evolving threat to global health. Addressing this challenge requires continuous research and innovative solutions in prevention, diagnosis, and treatment.

Initial Source for content: Gemini AI Overview  7/16/25

[Enter your questions, feedback & content (e.g. blog posts, Google Slide or Word docs, YouTube videos) on innovative research related to this post in the “Comment” section below.  Post curators will review your comments & content and decide where and how to include it in this section.]

1. Advancements in vaccine development

  • mRNA Technology
    The COVID-19 pandemic significantly accelerated the development and application of mRNA vaccines, demonstrating their potential for rapid and flexible production against diverse pathogens.

  • Plant-based Vaccines
    This approach offers the promise of cost-effective and efficient vaccine production, particularly relevant for global accessibility.

  • Multipurpose Prevention Technologies
    Researchers are developing innovative strategies like vaginal microbicidal gels to protect women against sexually transmitted infections.

  • Vaccines against RSV
    Recent approvals of new vaccines against respiratory syncytial virus (RSV) highlight progress in protecting vulnerable populations like infants and older adults.

2. Innovative diagnostic tools and surveillance systems

  • Next-Generation Sequencing (NGS)
    NGS provides a rapid and sensitive method for pathogen detection, enabling the identification of various microorganisms and the characterization of antimicrobial resistance genes.

  • PCR-based Diagnostics
    The COVID-19 pandemic highlighted the widespread applicability of PCR for rapid pathogen detection and timely intervention.

  • Point-of-Care (POC) Diagnostics
    POC tests offer the advantage of immediate results at or near the patient’s location, improving disease control, particularly in resource-limited areas.

  • Wastewater Surveillance
    This innovative method enables early detection of infection trends in communities, even before symptoms appear, facilitating prompt public health interventions.

  • Geographic Information Systems (GIS) and Remote Sensing
    These technologies provide valuable insights into the geographic distribution and environmental factors associated with disease vectors and outbreaks.     

3. Technology-driven solutions

  • Artificial Intelligence (AI) and Machine Learning (ML)
    These technologies can analyze vast datasets to predict disease outbreaks, enhance diagnostics, and identify potential antimicrobial resistance.

  • Nanotechnology
    Nanoparticle-based platforms are being explored for targeted drug delivery, improved diagnostics, and novel pathogen detection tools.

  • Internet of Things (IoT)
    IoT devices can monitor environmental conditions, predict disease outbreaks, and enable real-time surveillance.

  • Blockchain Technology
    Blockchain can enhance supply chain management for vaccines and medications, ensuring transparency and facilitating data sharing for research collaborations.

4. Addressing antimicrobial resistance (AMR)

  • Novel Antibiotics and Therapies
    Research is focused on developing new antimicrobial agents to combat resistant strains of bacteria, including synthetic compounds and alternative therapies like phage therapy.

  • Understanding Resistance Mechanisms
    Studies are investigating the mechanisms by which bacteria develop resistance to antibiotics, aiming to inform the development of more effective treatments.     

5. Global collaboration and preparedness

  • Coordinated Responses
    The need for collaborative, worldwide frameworks for infectious disease research and control has been emphasized, highlighting the interconnected nature of global health.

  • Social Innovation
    Social innovations, including community engagement and the use of technology, play a crucial role in prevention and control efforts, according to research published in Infectious Diseases of Poverty.     

Projects

Initial Source for content: Gemini AI Overview  7/16/25

[Enter your questions, feedback & content (e.g. blog posts, Google Slide or Word docs, YouTube videos) on current and future projects implementing solutions to this post challenges in the “Comment” section below.  Post curators will review your comments & content and decide where and how to include it in this section.]

1. Advanced diagnostics and surveillance

  • Rapid and Point-of-Care (PoC) Diagnostics
    Developing rapid, sensitive, and portable tests for early and accurate pathogen detection is crucial, especially in resource-limited settings. Innovations include CRISPR-based diagnostic systems like SHERLOCK and DETECTR, which can detect specific nucleic acid sequences with high accuracy and speed. These technologies eliminate the need for expensive thermal cyclers and complex lab procedures, making them highly suitable for use in the field.

  • Wastewater Surveillance
    This innovative approach monitors pathogens in wastewater to identify infection trends even before symptoms emerge in a population. This provides an early warning system for potential outbreaks and allows for timely public health interventions.

  • Real-time Surveillance Systems
    AI and machine learning are increasingly used in real-time surveillance systems to continuously monitor and analyze various data streams, including hospital admissions, social media, and news reports. These systems can identify anomalies and patterns indicative of emerging outbreaks, enabling faster response times.

  • AI-Powered Genomic Sequencing Analysis
    AI algorithms can analyze vast datasets from genomic sequencing to identify novel pathogens, track their evolution and spread, and even predict mutations conferring drug resistance. This enhances our ability to develop effective treatment strategies and guide public health interventions.

2. Advanced therapies and prevention

  • Vaccine Development and Delivery
    mRNA technology has revolutionized vaccine development, enabling faster production and greater flexibility in responding to emerging threats. Research is focused on improving RNA vaccine technologies, including developing self-amplifying RNA (saRNA) and circular RNA (circRNA) vaccines for broader protection and increased durability. Novel delivery systems, such as lipid nanoparticles (LNPs) and virus-like particles (VLPs), are being explored to enhance vaccine stability and delivery efficiency.

  • Novel Antimicrobials
    The rise of antimicrobial resistance (AMR) necessitates the development of new antibiotics that can overcome the defenses of drug-resistant bacteria. Research is focused on finding new molecules with novel mechanisms of action, overcoming the challenges associated with drug penetration into bacteria.

  • CRISPR-Based Therapies
    CRISPR technology holds promise for treating viral and bacterial infections by targeting and cleaving pathogenic DNA or RNA sequences. CRISPR systems are being developed to eliminate integrated viral genomes in latent or chronic infections (e.g., HIV-1, HBV) and to target antibiotic-resistance genes in bacteria.

  • Nanotechnology in Antiviral Therapy and Drug Delivery
    Nanoparticles (NPs) are being developed as drug carriers to enhance the delivery of antiviral and antibacterial medications to target cells and tissues. They offer advantages like increased solubility, improved targeting, and reduced toxicity compared to conventional drug delivery methods.

  • Neurofeedback Training
    EEG devices are being investigated to train individuals to modify brainwave activity patterns associated with different sleep stages, with the goal of improving sleep quality and duration in cases of insomnia.

3. Addressing the impact of climate change

  • Integrated Surveillance and Modeling Platforms
    Multi-disciplinary collaborations are needed to develop platforms integrating climate data, epidemiological data, and other factors using AI to understand and predict the impact of climate change on infectious diseases. These platforms can help track and model the potential responses of emerging infectious diseases (EIDs) to altered climate conditions, guiding research on early detection, diagnostics, and vaccine development.

  • Forecasting Future Burdens
    Projects focus on developing models to forecast the future burden of specific EIDs under different climate change scenarios, leveraging past epidemic and pandemic data to inform preparedness and response strategies.

4. The One Health approach

  • Interconnected Health
    The One Health approach recognizes the close links between the health of humans, animals, plants, and ecosystems, emphasizing the need for collaboration across relevant sectors to address infectious disease challenges.

  • Addressing Zoonoses, Vector-borne Diseases, and Antimicrobial Resistance (AMR)
    This approach focuses on tackling issues like zoonotic diseases, vector-borne diseases, AMR, and food safety by integrating surveillance, prevention, and treatment efforts across human, animal, and environmental domains.